IBR900 Cell Injection Combined With Lenvatinib or Bevacizumab in the Treatment of Advanced Primary Liver Cancer
Clinical trial NCT05411757 · UNKNOWN
Trial details
- NCT number
- NCT05411757
- Sponsor
- Shandong Public Health Clinical Center
- Status
- UNKNOWN
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-30
- Primary completion
- 2023-06-30
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.